Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombinant vaccinia virus vector with D8L gene knocked out

A vaccinia virus vector and vaccinia virus technology, applied in the fields of molecular biology and immunology, can solve problems such as limiting the repeated or multiple application of vaccinia virus vectors, affecting the reinfection of the target recombinant vaccinia virus vector, and affecting the delivery effect of viral vector drugs , to achieve the effect of increasing the number of uses

Pending Publication Date: 2021-08-31
VACDIAGN BIOTECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the high level of neutralizing antibodies in the body will greatly affect the reinfection of the target recombinant vaccinia virus vector, thereby affecting the drug delivery effect of the viral vector
This feature also limits the repeated or multiple applications of vaccinia virus vectors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant vaccinia virus vector with D8L gene knocked out
  • Recombinant vaccinia virus vector with D8L gene knocked out
  • Recombinant vaccinia virus vector with D8L gene knocked out

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0078] The present invention also provides a preparation method for constructing a D8L gene knockout recombinant vaccinia vector, comprising the following steps:

[0079] Step 1: designing primers to amplify the two homologous recombination arms of D8L by PCR respectively.

[0080] Step 2: Insert the two homologous recombination arms into the target shuttle vector to construct a shuttle vector containing the sequence of the D8L homologous recombination arm.

[0081] Step 3, transfecting the shuttle vector into vaccinia virus-infected cells.

[0082] Step 4, collecting the recombinant vaccinia virus vector from the cells, and performing single-spot purification on new cells.

[0083] Wherein, the primer is a primer sequence that can bind to both ends of D8L, preferably SEQ ID NO:3D8L-LC-F primer, SEQ ID NO:4D8L-LC-R primer, SEQ ID NO:5D8L-RC-F primer or SEQ ID NO : 6D8L-RC-R primer.

[0084] The shuttle vector is characterized by containing the D8L homologous recombination a...

Embodiment 1

[0098] Example 1 Construction of pΔD8L-GFP shuttle vector.

[0099] By designing primers (Table 1) on the Tiantan strain poxvirus TP5 clone genome (Genbank: KC207811) sequence, the genomic DNA of vaccinia virus wild-type rvv-WT (provided by Beijing Biological Products) (preparation method reference example 3) For template (respectively amplify D8L-L (SEQ ID NO: 1) and D8L-R (SEQ ID NO: 2) fragments, wherein, D8L-LC-F and D8L-LC-R primer pair is used for amplifying D8L- The L fragment, D8L-RC-F and D8L-RC-R primer pair were used to amplify the D8L-R fragment.

[0100] Table 1: Primers in Example 1

[0101]

[0102]

[0103] The first step is to construct the intermediate vector pΔD8L-L with D8L-L homologous recombination arm. First, use the pSC65-GFP vector transformed from the pSC65 shuttle vector (addgene, catalog number: 30327) (replacing the LacZ expressing galactosidase on the pSC65 vector with the EGFP gene expressing green fluorescent protein, provided by Suzhou ...

Embodiment 2

[0107] Example 2 Construction of recombinant vaccinia virus vector rvv-ΔD8L / G.

[0108] The recombinant vaccinia virus vector was obtained in 293T cells, and the specific method was as follows. On the first day, 293T cells were plated in 6-well cell culture plates (JET, TCP-010-006), 1×10 6 / well and incubated overnight at 37°C in a carbon dioxide cell incubator. On the second day, at 0.05MOI (ie 5×10 4 PFU (plaque forming unit) / well) was added to vaccinia virus wild strain rvv-WT (provided by Beijing Biological Products), and then placed in a 37°C carbon dioxide cell incubator and incubated for two hours, during which the shuttle vector / transfection reagent was prepared Complex. Wherein the shuttle carrier is the complex obtained from p obtained in Example 1. Among them, the transfection reagent is Turbofect (Thermo Fisher Scientific, R0531), and the transfection dose and compounding method can be found in the instructions of the transfection reagent. After the complex s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of molecular biology and immunology, in particular to a recombinant vaccinia virus vector with a D8L gene knocked out. The recombinant vaccinia virus vector has a D8L homologous recombinant arm sequence, and recombinant virus vector is used for constructing a vaccinia virus vector for inserting an exogenous gene in a D8L gene region of vaccinia virus. The invention provides a recombinant vaccinia virus vector capable of escaping the existing anti-vaccinia virus neutralizing antibody existing in the body, the D8L coding gene is knocked out or damaged, the D8L gene cannot be normally expressed, and the vaccinia virus vector can be used as a tumor vaccine or a gene therapy vector and can be used for preventing or treating various tumors.

Description

technical field [0001] The invention relates to the technical fields of molecular biology and immunology, in particular to a recombinant vaccinia virus vector for knocking out D8L gene. Background technique [0002] Vaccinia Virus (Vaccinia Virus) belongs to the Poxviridae Orthomyxovirus genus. It was once used as a vaccine to prevent smallpox infection and has been widely used in the world, making smallpox the first malignant infectious disease completely exterminated by humans (Riva, G. et al., 1979. Amilestone in the history of mankind. Eradication of smallpox. MMW Munch Med Wochenschr, 121(50), 1669-70). In the past two decades, with the rapid development of genetic engineering technology, vaccinia virus has been used to study and design gene expression vectors, or for the research of recombinant live virus vaccines (Moss, B.1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 93(21), 11341-8; Paoletti,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/863C12N15/39C12N15/65C12N15/90
CPCC12N15/85C12N15/65C12N15/902C07K14/005C12N2710/24022C12N2710/24043
Inventor 徐建青王璐黄杨
Owner VACDIAGN BIOTECH